Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-23T22:43:17.360Z Has data issue: false hasContentIssue false
  • English
  • Français

Epidemiology of Ventilator-Associated Pneumonia in a Long-Term Acute Care Hospital

Published online by Cambridge University Press:  02 January 2015

Allan J. Walkey ,
Christine Campbell Reardon ,
Carol A. Sulis ,
R. Nicholas Nace  and
Martin Joyce-Brady
Allan J. Walkey
Affiliation:
Boston University School of Medicine, Boston, Massachusetts
Christine Campbell Reardon
Affiliation:
Boston University School of Medicine, Boston, Massachusetts Radius Specialty Hospital, Boston, Massachusetts
Carol A. Sulis
Affiliation:
Boston University School of Medicine, Boston, Massachusetts Radius Specialty Hospital, Boston, Massachusetts
R. Nicholas Nace
Affiliation:
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Martin Joyce-Brady*
Affiliation:
Boston University School of Medicine, Boston, Massachusetts Radius Specialty Hospital, Boston, Massachusetts
*
The Pulmonary Center, Boston University School of Medicine, R-304, 715 Albany Street, Boston, MA 02118 (mjbrady@bu.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To characterize the epidemiology and microbiology of ventilator-associated pneumonia (VAP) in a long-term acute care hospital (LTACH).

Design.

Retrospective study of prospectively identified cases of VAP.

Setting.

Single-center, 207-bed LTACH with the capacity to house 42 patients requiring mechanical ventilation, evaluated from April 1, 2006, through January 31, 2008.

Methods.

Data on the occurrence of VAP were collected prospectively as part of routine infection surveillance at Radius Specialty Hospital. After March 2006, Radius Specialty Hospital implemented a bundle of interventions for the prevention of VAP (hereafter referred to as the VAP-bundle approach). A case of VAP was defined as a patient who required mechanical ventilation at Radius Specialty Hospital for at least 48 hours before any symptoms of pneumonia appeared and who met the Centers for Disease Control and Prevention criteria for VAP. Sputum samples were collected from a tracheal aspirate if there was clinical suspicion of VAP, and these samples were semi-quantitatively cultured.

Results.

During the 22-month study period, 23 cases of VAP involving 19 patients were associated with 157 LTACH admissions (infection rate, 14.6%), corresponding to a rate of 1.67 cases per 1,000 ventilator-days, which is a 56% reduction from the VAP rate of 3.8 cases per 1,000 ventilator-days reported before the implementation of the VAP-bundle approach (P<.001). Microbiological data were available for 21 (91%) of 23 cases of VAP. Cases of VAP in the LTACH were frequently polymicrobial (mean number ± SD, 1.78 ± 1.0 pathogens per case of VAP), and 20 (95%) of 21 cases of VAP had at least 1 pathogen (Pseudomonas species, Acinetobacter species, gram-negative bacilli resistant to more than 3 antibiotics, or methicillin-resistant Staphylococcus aureus) cultured from a sputum sample. LTACH patients with VAP were more likely to have a neurological reason for ventilator dependence, compared with LTACH patients without VAP (69.6% of cases of VAP vs 39% of cases of respiratory failure; P = .014). In addition, patients with VAP had a longer length of LTACH stay, compared with patients without VAP (median length of stay, 131 days vs 39 days; P = .002). In 6 (26%) of 23 cases of VAP, the patient was eventually weaned from use of mechanical ventilation. Of the 19 patients with VAP, 1 (5%) did not survive the LTACH stay.

Conclusions.

The VAP rate in the LTACH is lower than the VAP rate reported in acute care hospitals. Cases of VAP in the LTACH were frequently polymicrobial and were associated with multidrug-resistant pathogens and increased length of stay. The guidelines from the Centers for Disease Control and Prevention that are aimed at reducing cases of VAP appear to be effective if applied in the LTACH setting.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 4 , April 2009 , pp. 319 - 324
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Centers for Disease Control and Prevention (CDC). Guidelines for the Prevention of Nosocomial Pneumonia. MMWR Recomm Rep 1997;46(RR-1)):1–79.Google Scholar
2.Safdar, N, Dezfulian, C, Collard, HR, et al.Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:2184–2193.Google Scholar
3.Chastre, J, Fagon, JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867–903.CrossRefGoogle ScholarPubMed
4.National Nosocomial Infection Surveillance (NNIS) System Report, data summary January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.Google Scholar
5.American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388–416.CrossRefGoogle Scholar
6.Rello, J, Ollendorf, DA, Oster, G, et al.Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115–2121.CrossRefGoogle Scholar
7.Tablan, OC, Anderson, LJ, Besser, R, et al.; Centers for Disease Control and Prevention (CDC); Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care–associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53(RR-3)):1–36.Google Scholar
8.Zach, JE, Garrison, T, Trovillion, E, et al.Effect of an education program aimed at reducing the rate of ventilator-associated pneumonia. Crit Care Med 2002;30:2407–2412.Google Scholar
9. Medicare Payment Advisory Commission. Defining long-term care hospitals, chap. 5. June 2004. Available at: http://www.medpac.gov/publications/congressional_reports/June04_ch5.pdf. Accessed August 20, 2008.Google Scholar
10.Scheinhorn, DJ, Hassenpflug, MS, Votto, JJ, et al.Post-ICU mechanical ventilation at 23 long-term care hospitals: a multicenter outcomes study. Chest 2007;131:85–93.Google Scholar
11.Horan, TC, Gaynes, RP. Surveillance of nosocomial infections. In: Mayhall, CG, ed. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004:1659–1702.Google Scholar
12.Canadian Clinical Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006;355:2619–2630.Google Scholar
13.Nseir, S, Di Pompeo, C, Jozefowicz, E, et al.Relationship between tracheostomy and ventilator-associated pneumonia: a case-control study. Eur Respir J 2007;30:314–320.Google Scholar
14.Chenoweth, CE, Washer, LL, Obeyesekera, K, et al.Ventilator-associated pneumonia in the home care setting. Infect Control Hosp Epidemiol 2007;28:910–915.CrossRefGoogle ScholarPubMed
15.Jackson, MM, Fierer, J, Barrett-Connor, E, et al.Intensive surveillance for infections in a three-year study of nursing home patients. Am J Epidemiol 1992;135:685–696.Google Scholar
16.Kollef, MH, Silver, P, Murphy, DM, Trovillion, E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995;108:1655–1662.Google Scholar
17.Combes, A, Figlioni, C, Trouillet, JL, et al.Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest 2002;121:1618–1623.Google Scholar
18.Cook, DJ, Walter, SD, Cook, RJ, et al.Incidence and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Int Med 1998;129:433–440.Google Scholar
19.Hendra, KP, Bonis, PA, Joyce-Brady, M. Development and prospective validation of a model for predicting weaning in chronic ventilator dependent patients. BMC Pulm Med 2003;3:3.Google Scholar